Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass

Heart

Volumn 77, Issue 1, 1997, Pages 24-31

  Schunkert, Heribert ^a   Hense, Hans Werner ^b,c   Muscholl, Michael ^a   Luchner, Andreas ^a   Kürzinger, Susanne ^a   Danser, A H Jan ^d   Riegger, Günter A J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

aldosterone; angiotensin converting enzyme; angiotensinogen; left ventricular hypertrophy

Indexed keywords

ALDOSTERONE; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; PRORENIN; RENIN;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; ELECTROCARDIOGRAM; ENZYME ACTIVITY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031045937     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.77.1.24     Document Type: Article

References (59)

1. Kannel WB, Gordon T, Castelli WP, Margolia JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. Ann Intern Med 1970;72: 813-22.
2. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988;108:7-13.
3. Sullivan JM, Van der Zwaag R, El-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol 1993;22;508-13.
4. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
5. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975;56:56-64.
6. Morgan HE, Baker K. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 1991;83: 13-26.
7. Khairallah PA, Kanabus J. Angiotensin and myocardial protein synthesis. Perspect Cardiovasc Res 1983;8:337-47.
8. 1-adrenergic response. J Clin Invest 1983;72:732-8.
9. Schunkert H, Sadoshima J, Kagaya Y, Weinberg EO, Izumo S, Riegger G, et al. Angiotensin II-induced growth responses in isolated rat hearts: evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res 1995;76:489-97.
10. Schunkert H, Hense HW, Holmer SR, Stender K, Perz S, Keil U, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330: 1634-8.
11. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90:2622-8.
12. Ohishi M, Raguki H, Ogihara T. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy (letter). N Engl J Med 1994;331:1097.
13. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
14. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40
15. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. Absence of association or genetic linkage between the angiotensin-converting enzyme gene and left ventricular mass. N Engl J Med 1996;334:1023-8.
16. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) controls plasma ACE. Am J Hum Genet 1992;51:197-205.
17. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, et al. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993;21:455-60.
18. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, et al. Plasma level and gene polymorphism of angiotensin converting enzyme in relation to myocardial infarction. Circulation 1994;90:669-76.
19. Keil U, Stieber J, Doring A, Chambless L, Härtel U, Filipatrik B, et al. The cardiovascular risk factor profile in the study area Augsburg: results from the first MONICA survey 1984/1985. Acta Med Scand 1988;728(suppl): 119-28.
20. Gardin JM, Siscovick D, Anton-Culver H, Lynch JC, Smith VE, Klopfenstein S, et al. Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. Circulation 1995;91: 1739-48.
21. Sahn D, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: results on a survy of echocardiographic measurements. Circulation 1978;58:1072-83.
22. Devereux RB, Koren MJ, deSimone P, Okin N, Klingfield P. Methods for detection of left ventricular hypertrophy: application to hypertensive heart disease. Eur Heart J 1993;14(suppl D):8-15.
23. Ganau A, Devereux RB, Roman RJ, De Simone G, Pickering T, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992;19:1550-8.
24. Derkx FHM, Deinum J, Lipovski M, Verhaar M, Fischli W, Schalekamp MADH. Nonproteolytical "activation" of prorenin by active site-directed renin inhibitors as demonstrated by rerun specific monoclonal antibody. J Biol Chem 1992;267:22837-42.
25. Derkx FHM, deBruin RJA, van Gool JMG, Rosmalen FMA, van Hoek MJC, Beerendonk CCM, et al. A novel assay of plasma prorenin using a renin inhibitor. J Hypertens 1993;11 (suppl 5):S240-1.
26. Schunkert H, Ingelfinger JR, Hirsch AT, Tang SS, Litwin S, Talsness C, et al. Evidence for tissue specific activation of renal angiotensinogen mRNA expression in chronic stable heart failure. J Clin Invest 1992;90:1523-9.
27. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein C, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA levels in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J Clin Invest 1990; 86:1913-20.
28. Lauer MS, Anderson KM, Kannel, WB, Levy D. The impact of obesity on left ventricular mass and geometry. JAMA 1991;266:231-6.
29. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, et al. Relationships between angiotensin I-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994; 43:384-8.
30. Bonithon-Kopp C, Ducimetiere P, Touboul PJ, Feve JM, Billaud E, Courbon D, et al. Plasma angiotensin I-converting enzyme activity and carotid wall thickening. Circulation 1994;89:952-4.
31. Payne MN, McDonald F, Murray RG, Barlett WA. Plasma angiotensin-converting enzyme activity and carotid wall thickening (letter). Circulation 1994;90:2566.
32. Caulfield M, Newell-Price J. The angiotensin converting enzyme gene in cardiovascular disease. Br Heart J 1995;74:207-8.
33. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, et al. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342: 1073-5.
34. Miyasaki M, Okunishi H, Okamura T, Toda N. Elevated vascular angiotensin converting enzyme in chronic two kidney, one clip hypertension in the dog. J Hypertens 1987;5:155-60.
35. Raguki H, Kim DK, Krieger JE, Dzau VJ, Pratt R. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest 1994;93:339-46.
36. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Jacob H, Dzau VJ. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993;72:312-8.
37. Danser AHJ, Schalekamp MADH, Riegger GAJ, Schunkert H. Angiotensin converting enzyme in the human heart: effects of the deletion/insertion polymorphism. Circulation 1995;92:1388-9.
38. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91:3662-5.
39. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-202.
40. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary heart disease in the Caephilly Heart Study. Circulation 1995;91:270-4.
41. Badenhop RF, Wang XL, Wilcken DEL. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995;91:1655-8.
42. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995;91:2120-4.
43. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 1994; 43:690-5.
44. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
45. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Br Med J 1994;309:1608-12.
46. Krege JH, John SWM, Langenbach LL, Hodgin JB, Hagaman JR, Bachmann ES, a al. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995;375:146-8.
47. Harris EL, Phelan EL, Thompson CM, Millar JA, Grigor MR. Heart mass and blood pressure have separate genetic determinatns in the New Zealand genetically hypertensive (GH) rat. J Hypertens 1995;13:397-404.
48. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin angiotensin aldosterone system. Circulation 1991;83:1849-65.
49. Duprez DA, Bauwens FR, deBuyzere ML, de Backer TL, Kaufman JM, van Hoecke J, et al. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1993;71:17A-20A.
50. Navarro-Lopez F, Coca A, Pare JC, dela Sierra A, Bosch X, Urbano Marquez A. Left ventricular hypertrophy in asymptomatic essential hypertension: its relationship with aldosterone and the increase in sodium-proton exchanger activity. Eur Heart J 1993;14(suppl J):38-41.
51. Denolle T, Chatellier G, Julien J, Battaglia C, Luo P, Plouin PF. Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone producing adenoma, and pheochromocytoma. Am J Hypertens 1993;6:907-13.
52. Elkik F, Gompel A, Mecier-Bodard C, Kuttenn F, Guyenne PN, Corvol P, et al. Effects of percutaneous estradiol and conjugated estragens on the level of plasma proteins and trigycerides in postmenopausal women. Amer J Obstet Gynec 1982;143:888-92.
53. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71: 169-80.
54. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, et al. Genetic variation of the angiotensinogen locus in relation to high blood pressure and myocardial infarction. The ETCIM study. J Hypertens 1995;13:311-8.
55. Lindpaintner K, Sen S. Role of sodium in hypertensive cardiac hypertrophy. Circ Res 1985;57:610-7.
56. Devereux RB, Pickering TG, Cody RJ, Laragh JH. Relation of the renin angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension. J Clin Hypertens 1987;3: 87-103.
57. Rowlands DB, Glover DR, Ireland MA, McLeay RAB, Stallard TJ, Watson RDS, et al. Assessment of left ventricular mass and its response to antihypertensive treatment. Lancet 1982;i:467-70.
58. Devereux RB, Savage DD, Sachs I, Laragh JH. Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. Am J Cardiol 1983;51: 171-6.
59. Rizzoni D, Miuesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 1992;5:180-6.